報價延遲最少15分鐘:2025/05/23 07:16 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.19 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.51/-1.09
|
|
企業價值
35.31M
|
| 資產負債 |
|
每股賬面淨值
2.43
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/23 07:16 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. |